|
KR20040020107A
|
|
Isoform of FGFR2 in cancer cells
|
|
KR20040014691A
|
|
Oligopeptide which binds specifically to chondrocytes
|
|
KR20040014006A
|
|
Oligopeptide which binds specifically to hydroxyapatite
|
|
KR20030088257A
|
|
Oligopeptide which binds specifically to cell
|
|
KR20030087430A
|
|
Oligopeptide which binds specifically to Ti metal
|
|
KR20030087276A
|
|
Oligopeptide which binds specifically to PLGA
|
|
KR20030087278A
|
|
Oligopeptide which binds specifically to chitosan
|
|
KR20030086779A
|
|
Method for increasing adhesion of neuron using tenascin typeⅢ 3 fragment
|
|
KR20030086778A
|
|
Oligopeptide which binds specifically to Schwann cell
|
|
KR20010001604A
|
|
Moldable drug releasing barrier membranes and their fabrication method
|
|
KR20000075142A
|
|
Bone substituent consisting of biodegradable porous calcium metaphosphate and its process of preparation
|
|
KR100231279B1
|
|
Biodegradable polysaccharide sponge type formulation containing tissue growth factors for osteoblast implantation to recover
|
|
KR920005648B1
|
|
Dental applicable released composition containing antibiotics
|
